abagovomab 7
abciximab 11
abituzumab 4
abrilumab 7
actoxumab 6
adalimumab 7
aducanumab 3
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 17
alirocumab 6
amatuximab 13
andecaliximab 9
anifrolumab 7
anrukinzumab 7
aprutumab 6
aprutumab_ixadotin 6
arcitumomab 6
ascrinvacumab 0
atezolizumab 9
atinumab 9
avelumab 3
basiliximab 3
bavituximab 6
begelomab 5
benralizumab 0
bevacizumab_beta 3
bezlotoxumab 6
bimagrumab 8
bleselumab 0
blinatumomab 9
blosozumab 15
bococizumab 11
brazikumab 0
brentuximab_vedotin 3
briakinumab 6
brodalumab 0
brolucizumab 13
brontictuzumab 10
burosumab 10
cabiralizumab 7
camrelizumab 3
canakinumab 12
cantuzumab_ravtansin 12
carlumab 7
carotuximab 3
cergutuzumab_amunaleukin2 17
cergutuzumab_amunaleukin 17
certolizumab_pegol 10
cetiximab 17
citatuzumab_bogatox 16
cixutumumab 12
clivatuzumab_tetraxetan 0
codrituzumab 13
conatumumab 3
concizumab 6
crenezumab 4
crizanlizumab 3
crotedumab 9
dacetuzumab 13
daclizumab 5
dalotuzumab 10
dapirolizumab_pegol 12
daratumumab 10
dectrekumab 3
demcizumab 10
denosumab 7
depatuxizumab 5
depatuxizumab_mafodotin 5
dezamizumab 0
dinutuximab 14
diridavumab 0
domagrozumab 5
drozitumab 4
duligotuzumab 11
durvalumab 0
dusigitumab 0
efalizumab 17
efungumab 5
eldelumab 4
elezanumab 3
elgemtumab 0
elotuzumab 4
emactuzumab 7
emapalumab 6
emibetuzumab 5
enavatuzumab 18
enfortumab_vedotin 0
enoblituzumab 7
enokizumab 8
enoticumab 8
ensituximab 10
eptinezumab 8
erenumab 0
etaracizumab 9
etrolizumab 7
evinacumab 9
evolocumab 3
farletuzumab 0
fasinumab 10
fezakinumab 3
fibatuzumab 0
ficlatuzumab 7
firivumab 15
flanvotumab 3
fletikumab 10
foralumab 3
foravirumab 7
fremanezumab 12
fresolimumab 10
fulranumab 7
futuximab 4
galcanezumab 0
ganitumab 12
gantenerumab 0
gemetuzumab 11
gemtuzumab2 13
gemtuzumab 5
gevokizumab 10
girentuximab 7
glembatumumab 6
glembatumumab_vedotin 6
guselkumab 11
ibalizumab 7
ibritumomab 5
icrucumab 5
idarucizumab 3
ifabotuzumab 0
imalumab 10
imgatuzumab 5
inclacumab 6
indatuximab_ravtansin 12
indusatumab 4
inebilizumab 10
intetumumab 3
iodine_girentuximab 13
ipilimumab 0
iratumumab 4
isatuximab 5
itolizumab 13
ixekizumab 11
labetuzumab_govitecan 13
lambrolizumab 11
lampalizumab 10
lanadelumab 12
landogrozumab 9
laprituximab 12
lebrikizumab 11
lendalizumab 13
lenzilumab 0
lifastuzumab_vedotin 3
ligelizumab 7
lilotomab 6
lirilumab 4
lodelcizumab 6
lokivetmab 7
lorvotuzumab_mertansin 0
lucatumumab 17
lumretuzumab 0
lupartumab 6
lutikizumab 8
margetuximab 16
milatuzumab 8
mirvetuximab 14
mirvetuximab_soravtansin 14
modotuximab 17
mogamulizumab 10
monalizumab 11
motavizumab 15
moxetumomab_pasudotox 6
namilumab 4
naratuximab 7
naratuximab_emtansin 7
narnatumab 7
navicixizumab2 14
navicixizumab 10
navivumab 4
necitumumab 3
nemolizumab 12
nesvacumab 7
nivolumab 5
obiltoxaximab 3
obinutuzumab 11
ocaratuzumab 11
ofatumumab 3
olaratumab 0
olokizumab 14
omalizumab 11
onartuzumab 3
ontuxizumab 0
opicinumab 11
orticumab 3
otelixizumab 10
oxelumab 4
ozanezumab 5
pamrevlumab 0
panobacumab 6
parsatuzumab 3
pasotuxizumab 16
pateclizumab 8
patritumab 8
pembrolizumab 11
perakizumab 6
pidilizumab 8
pinatuzumab_vedotin 0
plozalizumab 5
pogalizumab 8
polatuzumab_vedotin 10
ponezumab 11
prezalumab 10
pritoxaximab 9
quilizumab 8
racotumomab 10
radretumab 4
ralpancizumab 16
ramucirumab 7
ranevetmab 12
ranibizumab 3
refanezumab 7
remtolumab 5
rilotumumab 3
rinucumab 0
risankizumab 15
rituximab 3
rivabazumab 5
robatumumab 16
roledumab 8
romosozumab 7
rontalizumab 10
rosmantuzumab 5
rozanolixizumab 5
sacituzumab 6
sacituzumab_govitecan 6
samalizumab 11
sapelizumab 10
sarilumab 0
secukinumab 5
seribantumab 7
setoxaximab 15
sifalimumab 0
siltuximab 6
simtuzumab 10
sirukumab 6
solanezumab 17
solitomab 4
stamulumab 6
suptavumab 12
suvizumab 0
tabalumab 0
tadocizumab 0
tamtuvetmab 17
tanezumab 12
tarextumab 5
tavolixizumab 6
telisotuzumab 14
teplizumab 5
tesidolumab 6
tezepelumab 4
tigatuzumab 10
tildrakizumab 8
timolumab 4
tisotumab 3
tosatoxumab 14
tositumomab 5
tralokinumab 10
trastuzumab 17
tregalizumab 15
trevogrumab 7
ublituximab 11
urelumab 3
ustekinumab 9
utomilumab 11
vadastuximab 9
vadastuximab_talirin 9
vandortuzumab_vedotin 0
vantictumab 6
vanucizumab2 3
vanucizumab 6
varlilumab 10
vatelizumab 8
vedolizumab 0
veltuzumab 0
vesencumab 0
vorsetuzumab 9
vorsetuzumab_mafodotin 9
vunakizumab 10
xentuzumab 7
zatuximab 17
